Academy Registry Program Now Captures COVID-19 Data

Deanna Killackey; Terry Stanton

The Academy’s Registry Program is now collecting COVID-19 data through the capture of the International Classification of Diseases, 10th revision (ICD-10) code for COVID-19 confirmed diagnosis, U07.1. The new code is enabled across each of the AAOS registries, comprising the American Joint Replacement Registry (AJRR), Shoulder & Elbow Registry, Musculoskeletal Tumor Registry, and American Spine Registry, the latter a collaborative effort between the American Association of Neurological Surgeons and AAOS.

Presidential Symposium Addresses Quality and Value

Terry Stanton

During the 2020 Presidential Symposium titled, “Successful Musculoskeletal Care in the New Age: It’s All About Value and Outcomes,” 2019–2020 AAOS President Kristy L. Weber, MD, FAAOS, noted that during her past service as chair of the Committee of Research and Quality (CoRQ), she had come to perceive that “quality and value in patient care are at the core of what we do as doctors and surgeons.” This session provided updates and overviews of ways the Academy has progressed in the quality and value movement, along with areas where progress remains to be achieved.

Anticipate Cognitive Bias to Provide the Best Care

The first article in this series addressed how patient cognitive bias affects health. Cognitive biases are the shortcuts the human mind takes. They are helpful for split-second decisions and are often accurate. But they are sometimes inaccurate in important ways, and managing cognitive bias is an important aspect of helping people get and stay healthy with safety and effectiveness. This article addresses surgeon cognitive bias—and the foundation of techniques used to limit errors and harm from errors in medicine.

An Overview of the FDA Approval Process for Devices

Martha Murray, MD, MS, FAAOS; Jonathan Dubin, MD, FAAOS

In 1976, Congress passed the Medical Device Amendments Act, which granted the Food and Drug Administration (FDA) authority to regulate medical devices. Within the FDA, the Center for Devices and Radiological Health (CDRH) typically oversees the process; however, if a device includes a biologic component, the Center for Biologics Evaluation and Research may oversee its evaluation. At present, the CDRH regulates

Most Orthopaedic Surgeons Have a Screw Loose

Fred R.T. Nelson, MD, FAAOS, FAOA; Alan M. Reznik, MD, MBA, FAAOS

Editor’s note: This report is based on the ongoing series called “Basic Science Tips” by Fred R.T. Nelson, MD, FAAOS, FAOA, weekly emails highlighting interesting and clinically relevant orthopaedic basic science research. Initially, the emails were aimed at residents in training, but they have gained a wider readership over time. AAOS Now editorial board member Alan M. Reznik, MD, MBA, FAAOS, worked with Dr. Nelson to select “tips” with current and near-future clinical implications for practicing orthopaedic surgeons.

AAOS, OREF Collaborative Effort Helps Drive Funding for Targeted Clinical Research Needs

AAOS and the Orthopaedic Research and Education Foundation (OREF) announced a strategic partnership to help narrow the gap between clinical research funding and prioritized clinical research needs in musculoskeletal care.